Exploring the impact of anti-oestrogen resistance on the capacity of breast cancer cells to modulate bone cell function and their sensitivity to bisphosphonates
Acquired resistance to endocrine therapy is a major limiting factor for their clinical effectiveness, resulting in disease relapse and an associated poor prognosis. Acquired resistance is also associated with the development of an invasive and migratory phenotype in vitro that may promote metastatic...
Main Author: | Lymperatou, Dionysia |
---|---|
Published: |
Cardiff University
2017
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.738356 |
Similar Items
-
The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently
by: Dionysia Lymperatou, et al.
Published: (2013-01-01) -
Role of oestrogen receptor phosphorylation in the growth of endocrine-responsive and anti-oestrogen-resistant breast cancer cell lines
by: Britton, David J.
Published: (2005) -
Mechanisms of oestrogen receptor signalling in cultured bone and breast cells
by: Ong, Delia Bee-Bee
Published: (2004) -
Activation of the oestrogen receptor by oestrogen and anti-oestrogen
by: Evans, E.
Published: (1983) -
Regulation of oestrogen receptor and oestrogen responsive genes by insulin, IGF-I, oestrogen and antioestrogens in breast cancer cells
by: Clayton, Simon James
Published: (1995)